nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Alzheimer's disease: clinical trials and drug development
|
Mangialasche, Francesca |
|
2010 |
9 |
7 |
p. 702-716 15 p. |
artikel |
2 |
Alzheimer's disease prevention: a reality check
|
The Lancet Neurology, |
|
2010 |
9 |
7 |
p. 643- 1 p. |
artikel |
3 |
April, 2010
|
|
|
2010 |
9 |
7 |
p. 659- 1 p. |
artikel |
4 |
Asymptomatic embolisation for prediction of stroke in the Asymptomatic Carotid Emboli Study (ACES): a prospective observational study
|
Markus, Hugh S |
|
2010 |
9 |
7 |
p. 663-671 9 p. |
artikel |
5 |
Atenolol in uncomplicated hypertension: time for changes
|
Salinas, Alberto Morales |
|
2010 |
9 |
7 |
p. 652- 1 p. |
artikel |
6 |
Atenolol in uncomplicated hypertension: time for changes – Author's reply
|
Rothwell, Peter M |
|
2010 |
9 |
7 |
p. 652-653 2 p. |
artikel |
7 |
Cerebral microemboli: smoking gun or innocent bystanders?
|
Amarenco, Pierre |
|
2010 |
9 |
7 |
p. 644-645 2 p. |
artikel |
8 |
Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges
|
Pantoni, Leonardo |
|
2010 |
9 |
7 |
p. 689-701 13 p. |
artikel |
9 |
Effect modification and ischaemic stroke treatment
|
Hill, Michael D |
|
2010 |
9 |
7 |
p. 649-651 3 p. |
artikel |
10 |
Gavin Giovannoni
|
|
|
2010 |
9 |
7 |
p. 659- 1 p. |
artikel |
11 |
Genomics in our own hands
|
Williams, Ruth |
|
2010 |
9 |
7 |
p. 656-657 2 p. |
artikel |
12 |
Gluten sensitivity and the CNS: diagnosis and treatment
|
Hernández-Lahoz, Carlos |
|
2010 |
9 |
7 |
p. 653-654 2 p. |
artikel |
13 |
Gluten sensitivity and the CNS: diagnosis and treatment
|
Versino, Maurizio |
|
2010 |
9 |
7 |
p. 653- 1 p. |
artikel |
14 |
Gluten sensitivity and the CNS: diagnosis and treatment – Authors' reply
|
Hadjivassiliou, Marios |
|
2010 |
9 |
7 |
p. 654-655 2 p. |
artikel |
15 |
Improving combination trials for multiple sclerosis
|
Trojano, Maria |
|
2010 |
9 |
7 |
p. 646-647 2 p. |
artikel |
16 |
Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial
|
Kapoor, Raju |
|
2010 |
9 |
7 |
p. 681-688 8 p. |
artikel |
17 |
Memories of a neurosurgeon
|
Kitchen, Neil |
|
2010 |
9 |
7 |
p. 660-661 2 p. |
artikel |
18 |
Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial
|
Ravnborg, Mads |
|
2010 |
9 |
7 |
p. 672-680 9 p. |
artikel |
19 |
Molecular pathology in adult gliomas: diagnostic, prognostic, and predictive markers
|
Jansen, Michael |
|
2010 |
9 |
7 |
p. 717-726 10 p. |
artikel |
20 |
Multiple sclerosis: risk factors, prodromes, and potential causal pathways
|
Ramagopalan, Sreeram V |
|
2010 |
9 |
7 |
p. 727-739 13 p. |
artikel |
21 |
Neurocritical care: an emerging discipline
|
Kramer, Andreas |
|
2010 |
9 |
7 |
p. 661- 1 p. |
artikel |
22 |
News in brief
|
|
|
2010 |
9 |
7 |
p. 662- 1 p. |
artikel |
23 |
Ralph Sacco: putting the heart into neurology
|
Burton, Adrian |
|
2010 |
9 |
7 |
p. 658- 1 p. |
artikel |
24 |
Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis
|
Polman, Chris H |
|
2010 |
9 |
7 |
p. 740-750 11 p. |
artikel |
25 |
Stroke—a call for papers
|
Frankish, Helen |
|
2010 |
9 |
7 |
p. 651- 1 p. |
artikel |
26 |
Where next for stroke?
|
Spratt, Neil |
|
2010 |
9 |
7 |
p. 660- 1 p. |
artikel |
27 |
Where to go next with neuroprotection in multiple sclerosis?
|
Fazekas, Franz |
|
2010 |
9 |
7 |
p. 647-648 2 p. |
artikel |